SAN FRANCISCO, March 5 - Affymetrix spin-off Perlegen has begun to generate data on 50 genomes, in the initial phase of its strategy to generate a wealth of SNP data that can be used to forge alliances with companies seeking to do genetic association studies, Affymetrix CEO Stephen Fodor told GenomeWeb

"The project has started; the train is leaving the station," Fodor said following his presentation at the Genome Tri Conference.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.